BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci. 2003;94:901-905. [PMID: 14556664 DOI: 10.1111/j.1349-7006.2003.tb01373.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez-Pons M, Torres-Cintrón CR, Soto-Salgado M, Vargas-Ramos Y, Perez-Portocarrero L, Morgan DR, Cruz-Correa M. Racial/ethnic disparities in gastric cancer: A 15-year population-based analysis. Cancer Med 2023;12:1860-8. [PMID: 35785449 DOI: 10.1002/cam4.4997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tang D, Ni M, Zhu H, Cao J, Zhou L, Shen S, Peng C, Lv Y, Xu G, Wang L, Zou X. Differential prognostic implications of gastric adenocarcinoma based on Lauren's classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study. Ann Transl Med 2021;9:646. [PMID: 33987344 DOI: 10.21037/atm-20-7953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhu M, Liang Q, Chen T, Kong Q, Ye G, Yu S, Li X, He Q, Liu H, Hu Y, Yu J, Li G. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer. Clin Epigenetics 2021;13:22. [PMID: 33514440 DOI: 10.1186/s13148-020-00989-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Dutta A, Datta S, Snehlata. Epigenetic regulations in gastrointestine: Implications on sensitivity to ionizing radiation, inflammatory diseases, and cancer development. Epigenetics and Metabolomics 2021. [DOI: 10.1016/b978-0-323-85652-2.00011-7] [Reference Citation Analysis]
5 Zeng Z, Xie D, Gong J. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer. PeerJ 2020;8:e9624. [PMID: 32821544 DOI: 10.7717/peerj.9624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Costantini L, Molinari R, Farinon B, Merendino N. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. J Clin Med 2020;9:E360. [PMID: 32012980 DOI: 10.3390/jcm9020360] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
7 Samadani AA, Noroollahi SE, Mansour-ghanaei F, Rashidy-pour A, Joukar F, Bandegi AR. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect? Biomedicine & Pharmacotherapy 2019;109:144-56. [DOI: 10.1016/j.biopha.2018.10.094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
8 Mohsenzadeh M, Sadeghi RN, Vahedi M, Kamani F, Hashemi M, Asadzadeh H, Zali MR. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes. Cancer Biomark 2017;20:7-15. [PMID: 28759951 DOI: 10.3233/CBM-160331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Ye P, Shi Y, Li A. Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis. Front Physiol 2018;9:368. [PMID: 29719511 DOI: 10.3389/fphys.2018.00368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Matsuhashi N, Yoshida K, Yamaguchi K, Tanahashi T. Molecular Diagnosis and Targeted Therapy for Gastric Cancer. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy 2018. [DOI: 10.1007/978-981-10-6469-2_4] [Reference Citation Analysis]
11 Honma R, Goto K, Sakamoto N, Sekino Y, Sentani K, Oue N, Yasui W. Expression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer. Gastric Cancer 2017;20:960-9. [PMID: 28382457 DOI: 10.1007/s10120-017-0714-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
12 Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol 2017;14:467-78. [PMID: 28513632 DOI: 10.1038/nrgastro.2017.53] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 15.3] [Reference Citation Analysis]
13 Miller BF, Sánchez-Vega F, Elnitski L. The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation. Biomolecules 2016;6:E45. [PMID: 27879658 DOI: 10.3390/biom6040045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
14 Ding Y, Yang Q, Wang B, Ye G, Tong X. The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0165509. [PMID: 27824946 DOI: 10.1371/journal.pone.0165509] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Sugimoto R, Sugai T, Habano W, Endoh M, Eizuka M, Yamamoto E, Uesugi N, Ishida K, Kawasaki T, Matsumoto T, Suzuki H. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype. Int J Cancer 2016;138:1689-97. [PMID: 26538087 DOI: 10.1002/ijc.29916] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
16 Goto K, Ishikawa S, Honma R, Tanimoto K, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation. Oncogene 2016;35:3598-606. [PMID: 26640143 DOI: 10.1038/onc.2015.445] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
17 Moarii M, Reyal F, Vert JP. Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype. Hum Genomics 2015;9:26. [PMID: 26463173 DOI: 10.1186/s40246-015-0048-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
18 Oue N, Sentani K, Sakamoto N, Yasui W. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype. Cancer Sci. 2015;106:951-958. [PMID: 26033320 DOI: 10.1111/cas.12706] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
19 Li Y, Liang J, Hou P. Hypermethylation in gastric cancer. Clin Chim Acta. 2015;448:124-132. [PMID: 26148722 DOI: 10.1016/j.cca.2015.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
20 Ksiâa F, Ziadi S, Dhiab MB, Gacem RB, Trimeche M. Increased DNA methyltransferase 1 protein expression correlates significantly with intestinal histological type and gender in gastric carcinomas. Adv Med Sci 2015;60:50-7. [PMID: 25461380 DOI: 10.1016/j.advms.2014.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
21 Yoda Y, Takeshima H, Niwa T, Kim JG, Ando T, Kushima R, Sugiyama T, Katai H, Noshiro H, Ushijima T. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 2015;18:65-76. [PMID: 24510342 DOI: 10.1007/s10120-014-0348-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 10.1] [Reference Citation Analysis]
22 Shigeyasu K, Nagasaka T, Mori Y, Yokomichi N, Kawai T, Fuji T, Kimura K, Umeda Y, Kagawa S, Goel A, Fujiwara T. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer. PLoS One 2015;10:e0130409. [PMID: 26121593 DOI: 10.1371/journal.pone.0130409] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
23 Cho M, Eze O, Xu R. Molecular genetics of gastric adenocarcinoma in clinical practice. World J Med Genet 2014; 4(3): 58-68 [DOI: 10.5496/wjmg.v4.i3.58] [Reference Citation Analysis]
24 Yousuf A, Bhat MY, Pandith AA, Afroze D, Khan NP, Alam K, Shah P, Shah MA, Mudassar S. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell Oncol (Dordr). 2014;37:245-252. [PMID: 25008999 DOI: 10.1007/s13402-014-0179-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
25 Doolittle JM, Webster-Cyriaque J. Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesis. MBio. 2014;5:e01015-e01014. [PMID: 24781742 DOI: 10.1128/mbio.01015-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
26 Loh M, Liem N, Vaithilingam A, Lim PL, Sapari NS, Elahi E, Mok ZY, Cheng CL, Yan B, Pang B, Salto-Tellez M, Yong WP, Iacopetta B, Soong R. DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach. BMC Gastroenterol. 2014;14:55. [PMID: 24674026 DOI: 10.1186/1471-230x-14-55] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
27 Wang HL, Zhou PY, Liu P, Zhang Y. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis. Mol Biol Rep 2014;41:4481-92. [PMID: 24610350 DOI: 10.1007/s11033-014-3319-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Turner ES, Turner JR. Expanding the Lauren classification: a new gastric cancer subtype? Gastroenterology 2013;145:505-8. [PMID: 23891604 DOI: 10.1053/j.gastro.2013.07.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
29 Grabsch HI, Tan P. Gastric cancer pathology and underlying molecular mechanisms. Dig Surg 2013;30:150-8. [PMID: 23867592 DOI: 10.1159/000350876] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
30 Zouridis H, Deng N, Ivanova T, Zhu Y, Wong B, Huang D, Wu YH, Wu Y, Tan IB, Liem N. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med. 2012;4:156ra140. [PMID: 23076357 DOI: 10.1126/scitranslmed.3004504] [Cited by in Crossref: 126] [Cited by in F6Publishing: 140] [Article Influence: 12.6] [Reference Citation Analysis]
31 Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation. Hum Pathol. 2013;44:1055-1064. [PMID: 23266441 DOI: 10.1016/j.humpath.2012.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
32 Sapari NS, Loh M, Vaithilingam A, Soong R. Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One. 2012;7:e36275. [PMID: 22558417 DOI: 10.1371/journal.pone.0036275] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 5.8] [Reference Citation Analysis]
33 Kang GH. CpG island hypermethylation in gastric carcinoma and its premalignant lesions. Korean J Pathol 2012;46:1-9. [PMID: 23109971 DOI: 10.4132/KoreanJPathol.2012.46.1.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
34 Yao D, Shi J, Shi B, Wang N, Liu W, Zhang G, Ji M, Xu L, He N, Hou P. Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. Clin Chim Acta. 2012;413:787-794. [PMID: 22285775 DOI: 10.1016/j.cca.2012.01.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
35 Hughes LA, Khalid-de Bakker CA, Smits KM, van den Brandt PA, Jonkers D, Ahuja N, Herman JG, Weijenberg MP, van Engeland M. The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta. 2012;1825:77-85. [PMID: 22056543 DOI: 10.1016/j.bbcan.2011.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 69] [Article Influence: 1.4] [Reference Citation Analysis]
36 Johnson AR. Epigenetics, Nutrition, and Cancer. Nutrition in Epigenetics 2011. [DOI: 10.1002/9780470959824.ch7] [Reference Citation Analysis]
37 Arai E, Wakai-Ushijima S, Fujimoto H, Hosoda F, Shibata T, Kondo T, Yokoi S, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues. Pathobiology 2011;78:1-9. [PMID: 21474971 DOI: 10.1159/000322072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
38 Won CS, Cho MY, Kim HS, Suk KT, Kim JW, Park HJ, Jeon HK, Baik SK, Kwon SO. Effect ofHelicobacter pyloriInfection on p16, p53, CEA, EGFR Expression in Gastric Neoplasia. Korean J Helicobacter Up Gastrointest Res 2011;11:45. [DOI: 10.7704/kjhugr.2011.11.1.45] [Reference Citation Analysis]
39 Lee P, Jain S, Pincus MR, Xu R. Molecular Genetic Pathology of Solid Tumors. Henry's Clinical Diagnosis and Management by Laboratory Methods 2011. [DOI: 10.1016/b978-1-4377-0974-2.00076-2] [Reference Citation Analysis]
40 Becker K, Keller G. Gastric Cancer. eLS 2010. [DOI: 10.1002/9780470015902.a0006056.pub2] [Reference Citation Analysis]
41 Park SY, Kook MC, Kim YW, Cho NY, Jung N, Kwon HJ, Kim TY, Kang GH. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features. Virchows Arch. 2010;457:415-422. [PMID: 20737169 DOI: 10.1007/s00428-010-0962-0]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Park SY, Kook MC, Kim YW, Cho NY, Jung N, Kwon HJ, Kim TY, Kang GH. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features. Virchows Arch. 2010;457:415-422. [PMID: 20737169 DOI: 10.1007/s00428-010-0962-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
43 Kondo Y, Issa JP. DNA methylation profiling in cancer. Expert Rev Mol Med. 2010;12:e23. [PMID: 20663272 DOI: 10.1017/s1462399410001559] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
44 Ksiaa F, Ziadi S, Mokni M, Korbi S, Trimeche M. The presence of JC virus in gastric carcinomas correlates with patient's age, intestinal histological type and aberrant methylation of tumor suppressor genes. Mod Pathol 2010;23:522-30. [PMID: 20081806 DOI: 10.1038/modpathol.2009.184] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
45 Cheung HH, Lee TL, Rennert OM, Chan WY. DNA methylation of cancer genome. Birth Defects Res C Embryo Today 2009;87:335-50. [PMID: 19960550 DOI: 10.1002/bdrc.20163] [Cited by in Crossref: 103] [Cited by in F6Publishing: 109] [Article Influence: 7.9] [Reference Citation Analysis]
46 Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clin Chim Acta. 2009;404:128-133. [PMID: 19336228 DOI: 10.1016/j.cca.2009.03.044] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
47 Elistratova EV, Laktionov PP, Shelestuk PI, Tuzikov SA, Vlassov VV, Rykova EY. Immunochemical and molecular-Genetic markers in diagnostics of gastric cancer. Biochem Moscow Suppl Ser B 2009;3:33-43. [DOI: 10.1134/s1990750809010041] [Reference Citation Analysis]
48 Lima EM, Leal MF, Burbano RR, Khayat AS, Assumpção PP, Bello MJ, Rey JA, Smith MA, Casartelli C. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz J Med Biol Res 2008;41:539-43. [PMID: 18622497 DOI: 10.1590/s0100-879x2008000600017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
49 Hirst M, Marra MA. Epigenetics and human disease. Int J Biochem Cell Biol 2009;41:136-46. [PMID: 18852064 DOI: 10.1016/j.biocel.2008.09.011] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 5.3] [Reference Citation Analysis]
50 Kishimoto I, Mitomi H, Ohkura Y, Kanazawa H, Fukui N, Watanabe M. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. J Surg Oncol 2008;98:60-6. [PMID: 18484097 DOI: 10.1002/jso.21087] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
51 Teodoridis JM, Hardie C, Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett. 2008;268:177-186. [PMID: 18471961 DOI: 10.1016/j.canlet.2008.03.022] [Cited by in Crossref: 91] [Cited by in F6Publishing: 103] [Article Influence: 6.1] [Reference Citation Analysis]
52 Karpiński P, Sąsiadek MM, Blin N. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers. J Appl Genet 2008;49:1-10. [DOI: 10.1007/bf03195243] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
53 Kang GH, Lee S, Cho NY, Gandamihardja T, Long TI, Weisenberger DJ, Campan M, Laird PW. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest 2008;88:161-70. [PMID: 18158559 DOI: 10.1038/labinvest.3700707] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 8.4] [Reference Citation Analysis]
54 Pu RT, Sheng ZM, Michael CW, Rhode MG, Clark DP, O'Leary TJ. Methylation profiling of mesothelioma using real-time methylation-specific PCR: a pilot study. Diagn Cytopathol 2007;35:498-502. [PMID: 17636483 DOI: 10.1002/dc.20692] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
55 Nardone G, Compare D, De Colibus P, de Nucci G, Rocco A. Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Dig Dis 2007;25:225-9. [PMID: 17827945 DOI: 10.1159/000103890] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
56 Kim YH, Hong SJ, Jung YC, Kim SJ, Seo EJ, Choi SW, Rhyu MG. The 5'-end transitional CpGs between the CpG islands and retroelements are hypomethylated in association with loss of heterozygosity in gastric cancers. BMC Cancer 2006;6:180. [PMID: 16827945 DOI: 10.1186/1471-2407-6-180] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
57 Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer. 2006;106:1250-1259. [PMID: 16475210 DOI: 10.1002/cncr.21754] [Cited by in Crossref: 100] [Cited by in F6Publishing: 113] [Article Influence: 5.9] [Reference Citation Analysis]
58 Yasui W, Oue N, Kitadai Y, Nakayama H. Recent Advances in Molecular Pathobiology of Gastric Carcinoma. The Diversity of Gastric Carcinoma. [DOI: 10.1007/4-431-27713-7_3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
59 Kaneda A. DNA Methylation and Gastric Carcinoma. The Diversity of Gastric Carcinoma. [DOI: 10.1007/4-431-27713-7_6] [Reference Citation Analysis]
60 Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer. 2006;106:483-493. [PMID: 16362978 DOI: 10.1002/cncr.21657] [Cited by in Crossref: 103] [Cited by in F6Publishing: 116] [Article Influence: 6.1] [Reference Citation Analysis]
61 Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pébusque MJ, Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol 2006; 12(5): 691-696 [PMID: 16521180 DOI: 10.3748/wjg.v12.i5.691] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.1] [Reference Citation Analysis]
62 Koga Y, Kitajima Y, Miyoshi A, Sato K, Sato S, Miyazaki K. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. J Gastroenterol 2006;41:133-9. [PMID: 16568372 DOI: 10.1007/s00535-005-1732-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
63 Clément G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J Pathol 2006;208:100-7. [PMID: 16278815 DOI: 10.1002/path.1884] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 5.1] [Reference Citation Analysis]
64 Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006;20:651-74. [PMID: 16997151 DOI: 10.1016/j.bpg.2006.03.016] [Cited by in Crossref: 106] [Cited by in F6Publishing: 115] [Article Influence: 6.2] [Reference Citation Analysis]
65 Motoshita J, Oue N, Nakayama H, Kuraoka K, Aung PP, Taniyama K, Matsusaki K, Yasui W. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci. 2005;96:474-479. [PMID: 16108828 DOI: 10.1111/j.1349-7006.2005.00074.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
66 Hong SJ, Kim YH, Choi YD, Min KO, Choi SW, Rhyu MG. Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas. J Korean Med Sci 2005;20:790-805. [PMID: 16224153 DOI: 10.3346/jkms.2005.20.5.790] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
67 Sugai T, Habano W, Jiao YF, Suzuki M, Takagane A, Nakamura S. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers. Oncology 2005;68:548-57. [PMID: 16037688 DOI: 10.1159/000086999] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
68 Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005;25:197-222. [PMID: 15749238 DOI: 10.1016/j.cll.2004.12.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
69 Hong SH, Kim HG, Chung WB, Kim EY, Lee JY, Yoon SM, Kwon JG, Sohn YK, Kwak EK, Kim JW. DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci 2005;20:236-41. [PMID: 15831994 DOI: 10.3346/jkms.2005.20.2.236] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
70 Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol. 2005;205:65-73. [PMID: 15586362 DOI: 10.1002/path.1684] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 2.9] [Reference Citation Analysis]
71 Rashid A, Issa JP. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 2004;127:1578-88. [PMID: 15521024 DOI: 10.1053/j.gastro.2004.09.007] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 5.6] [Reference Citation Analysis]
72 Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol. 2005;131:19-25. [PMID: 15565457 DOI: 10.1007/s00432-004-0621-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 83] [Article Influence: 3.9] [Reference Citation Analysis]
73 Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K, Yasui W. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer. 2004;110:212-218. [PMID: 15069684 DOI: 10.1002/ijc.20090] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]